Cargando…

Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review

Non-tuberculous mycobacteria (NTM) are ubiquitous environmental microorganisms capable of a wide range of infections that primarily involve the lymphatic system and the lower respiratory tract. In recent years, cases of lung infection sustained by NTM have been steadily increasing, due mainly to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gramegna, Andrea, Lombardi, Andrea, Lorè, Nicola I., Amati, Francesco, Barone, Ivan, Azzarà, Cecilia, Cirillo, Daniela, Aliberti, Stefano, Gori, Andrea, Blasi, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273994/ https://www.ncbi.nlm.nih.gov/pubmed/35837393 http://dx.doi.org/10.3389/fimmu.2022.927049

Ejemplares similares

Non-tuberculous mycobacteria lung disease due to Mycobacterium chimaera in a 67-year-old man treated with immune checkpoint inhibitors for lung adenocarcinoma: infection due to dysregulated immunity?
por: Azzarà, Cecilia, et al.
Publicado: (2023)

Nontuberculous mycobacterial infections during cancer therapy with immune checkpoint inhibitors: a systematic review
por: Lombardi, Andrea, et al.
Publicado: (2022)

Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis
por: Faverio, Paola, et al.
Publicado: (2016)

Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis
por: Suska, Kseniia, et al.
Publicado: (2022)

The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol
por: Aliberti, Stefano, et al.
Publicado: (2018)

SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity
por: Blasi, Francesco, et al.
Publicado: (2021)

The biology of pulmonary exacerbations in bronchiectasis
por: Amati, Francesco, et al.
Publicado: (2019)

Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review
por: Amati, Francesco, et al.
Publicado: (2023)

Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience
por: Amati, Francesco, et al.
Publicado: (2022)

Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis
por: Bonaiti, Giulia, et al.
Publicado: (2015)

Neutrophil elastase in bronchiectasis
por: Gramegna, Andrea, et al.
Publicado: (2017)

Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia
por: Amati, Francesco, et al.
Publicado: (2023)

Prevalence and incidence of bronchiectasis in Italy
por: Aliberti, Stefano, et al.
Publicado: (2020)

Comments on “PD-1 Inhibitor for Disseminated Mycobacterium avium Infection in a Person Living With HIV”
por: Lombardi, Andrea, et al.
Publicado: (2023)

Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2023)

From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2020)

Specificity of the innate immune responses to different classes of non-tuberculous mycobacteria
por: Hu, Wanbin, et al.
Publicado: (2023)

Walking the path of treatable traits in interstitial lung diseases
por: Amati, Francesco, et al.
Publicado: (2023)

Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients
por: Terranova, Leonardo, et al.
Publicado: (2022)

Protease–Antiprotease Imbalance in Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)

Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement
por: Gramegna, Andrea, et al.
Publicado: (2018)

Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review
por: Lombardi, Andrea, et al.
Publicado: (2022)

T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)

T-Cell Exhaustion in Mycobacterium tuberculosis and Nontuberculous Mycobacteria Infection: Pathophysiology and Therapeutic Perspectives
por: Lombardi, Andrea, et al.
Publicado: (2021)

Comparison of different conditions for DNA extraction in sputum - a pilot study
por: Oriano, Martina, et al.
Publicado: (2019)

Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis
por: Sotgiu, Giovanni, et al.
Publicado: (2018)

Lung Recruitability of COVID-19 Pneumonia in Patients Undergoing Helmet CPAP
por: Amati, Francesco, et al.
Publicado: (2021)

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
por: Amati, Francesco, et al.
Publicado: (2022)

COVID-19 multidisciplinary high dependency unit: the Milan model
por: Aliberti, Stefano, et al.
Publicado: (2020)

Methods of phenotypic identification of non-tuberculous mycobacteria
por: Bhalla, Gurpreet S., et al.
Publicado: (2018)

The Incidence of Non-Tuberculous Mycobacteria in Infants in Kenya
por: Kaguthi, Grace, et al.
Publicado: (2019)

Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients
por: Aliberti, Stefano, et al.
Publicado: (2022)

Increasing Non-tuberculous Mycobacteria Infections in Veterans With COPD and Association With Increased Risk of Mortality
por: Pyarali, Fahim F., et al.
Publicado: (2018)

Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response
por: Pesce, Elisa, et al.
Publicado: (2022)

Frequency of tuberculous and non-tuberculous mycobacteria in HIV infected patients from Bogota, Colombia
por: Murcia-Aranguren, Martha I, et al.
Publicado: (2001)

Inventory study of non-tuberculous mycobacteria in the European Union
por: van der Werf, Marieke J, et al.
Publicado: (2014)

Surgical Site Infections due to Non-Tuberculous Mycobacteria
por: Yadav, Rohit Prasad, et al.
Publicado: (2018)

Pulmonary non-tuberculous mycobacteria in colonisation and disease in The Gambia
por: Okoi, Catherine, et al.
Publicado: (2022)

Non-Tuberculous Mycobacteria: Molecular and Physiological Bases of Virulence and Adaptation to Ecological Niches
por: Pereira, André C., et al.
Publicado: (2020)

Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria
por: Agizew, Tefera, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9q5vpddgf78gdigu2fi1cmgf0j